Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation

Autores
Al-Rasadi, Khalid; Rizzo, Manfredi; Montalto, Giuseppe; Berg, Gabriela Alicia
Año de publicación
2015
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Nonalcoholic fatty liver disease (NAFLD) is defined by excessive triglycerides (TGs) accumulation in the liver (>5% of hepatocytes histologically) in the absence of alcohol excess. The NAFLD ranges from simple steatosis to steatohepatitis and cirrhosis. The NAFLD and nonalcoholic steatohepatitis (NASH) are now the number one cause of liver disease in Western countries. The prevalence of NAFLD is increasing but is underreported, and the epidemiology and demographic characteristics vary worldwide.2 The prevalence is increasing because of the rising occurrence of obesity and type 2 diabetes (T2DM); in fact, NAFLD is considered as the hepatic manifestation of metabolic syndrome (MetS).
Fil: Al-Rasadi, Khalid. Sultan Qaboos University Hospital. Department of Clinical Biochemistry; Omán
Fil: Rizzo, Manfredi. Universidad de Palermo; Argentina
Fil: Montalto, Giuseppe. Universidad de Palermo; Argentina
Fil: Berg, Gabriela Alicia. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Materia
Non Alcoholic Fatty Liver Disease
Lipoproteins
Insulin Resistance
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/38786
Acceder
id CONICETDig_89ae7cf7dce21176889f4666c6f5480e
oai_identifier_str oai:ri.conicet.gov.ar:11336/38786
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid InflammationAl-Rasadi, KhalidRizzo, ManfrediMontalto, GiuseppeBerg, Gabriela AliciaNon Alcoholic Fatty Liver DiseaseLipoproteinsInsulin Resistancehttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Nonalcoholic fatty liver disease (NAFLD) is defined by excessive triglycerides (TGs) accumulation in the liver (>5% of hepatocytes histologically) in the absence of alcohol excess. The NAFLD ranges from simple steatosis to steatohepatitis and cirrhosis. The NAFLD and nonalcoholic steatohepatitis (NASH) are now the number one cause of liver disease in Western countries. The prevalence of NAFLD is increasing but is underreported, and the epidemiology and demographic characteristics vary worldwide.2 The prevalence is increasing because of the rising occurrence of obesity and type 2 diabetes (T2DM); in fact, NAFLD is considered as the hepatic manifestation of metabolic syndrome (MetS).Fil: Al-Rasadi, Khalid. Sultan Qaboos University Hospital. Department of Clinical Biochemistry; OmánFil: Rizzo, Manfredi. Universidad de Palermo; ArgentinaFil: Montalto, Giuseppe. Universidad de Palermo; ArgentinaFil: Berg, Gabriela Alicia. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaSAGE Publications2015-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/38786Al-Rasadi, Khalid; Rizzo, Manfredi; Montalto, Giuseppe; Berg, Gabriela Alicia; Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation; SAGE Publications; Angiology; 66; 7; 8-2015; 601-6030003-3197CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1177/0003319714557353info:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/0003319714557353info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-10T13:19:35Zoai:ri.conicet.gov.ar:11336/38786instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-10 13:19:36.038CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation
title Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation
spellingShingle Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation
Al-Rasadi, Khalid
Non Alcoholic Fatty Liver Disease
Lipoproteins
Insulin Resistance
title_short Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation
title_full Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation
title_fullStr Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation
title_full_unstemmed Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation
title_sort Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation
dc.creator.none.fl_str_mv Al-Rasadi, Khalid
Rizzo, Manfredi
Montalto, Giuseppe
Berg, Gabriela Alicia
author Al-Rasadi, Khalid
author_facet Al-Rasadi, Khalid
Rizzo, Manfredi
Montalto, Giuseppe
Berg, Gabriela Alicia
author_role author
author2 Rizzo, Manfredi
Montalto, Giuseppe
Berg, Gabriela Alicia
author2_role author
author
author
dc.subject.none.fl_str_mv Non Alcoholic Fatty Liver Disease
Lipoproteins
Insulin Resistance
topic Non Alcoholic Fatty Liver Disease
Lipoproteins
Insulin Resistance
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Nonalcoholic fatty liver disease (NAFLD) is defined by excessive triglycerides (TGs) accumulation in the liver (>5% of hepatocytes histologically) in the absence of alcohol excess. The NAFLD ranges from simple steatosis to steatohepatitis and cirrhosis. The NAFLD and nonalcoholic steatohepatitis (NASH) are now the number one cause of liver disease in Western countries. The prevalence of NAFLD is increasing but is underreported, and the epidemiology and demographic characteristics vary worldwide.2 The prevalence is increasing because of the rising occurrence of obesity and type 2 diabetes (T2DM); in fact, NAFLD is considered as the hepatic manifestation of metabolic syndrome (MetS).
Fil: Al-Rasadi, Khalid. Sultan Qaboos University Hospital. Department of Clinical Biochemistry; Omán
Fil: Rizzo, Manfredi. Universidad de Palermo; Argentina
Fil: Montalto, Giuseppe. Universidad de Palermo; Argentina
Fil: Berg, Gabriela Alicia. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
description Nonalcoholic fatty liver disease (NAFLD) is defined by excessive triglycerides (TGs) accumulation in the liver (>5% of hepatocytes histologically) in the absence of alcohol excess. The NAFLD ranges from simple steatosis to steatohepatitis and cirrhosis. The NAFLD and nonalcoholic steatohepatitis (NASH) are now the number one cause of liver disease in Western countries. The prevalence of NAFLD is increasing but is underreported, and the epidemiology and demographic characteristics vary worldwide.2 The prevalence is increasing because of the rising occurrence of obesity and type 2 diabetes (T2DM); in fact, NAFLD is considered as the hepatic manifestation of metabolic syndrome (MetS).
publishDate 2015
dc.date.none.fl_str_mv 2015-08
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/38786
Al-Rasadi, Khalid; Rizzo, Manfredi; Montalto, Giuseppe; Berg, Gabriela Alicia; Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation; SAGE Publications; Angiology; 66; 7; 8-2015; 601-603
0003-3197
CONICET Digital
CONICET
url http://hdl.handle.net/11336/38786
identifier_str_mv Al-Rasadi, Khalid; Rizzo, Manfredi; Montalto, Giuseppe; Berg, Gabriela Alicia; Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation; SAGE Publications; Angiology; 66; 7; 8-2015; 601-603
0003-3197
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1177/0003319714557353
info:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/0003319714557353
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv SAGE Publications
publisher.none.fl_str_mv SAGE Publications
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842981069560741888
score 12.48226

Publicaciones similares